On Oct 29, 2025, ATRC reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 91.46% surprise. Revenue reached 134.27 million, compared to an expected 133.88 million, with a 0.29% difference. The market reacted with a -3.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 142.05 million USD, implying an increase of 800.00% EPS, and increase of 5.80% in Revenue from the last quarter.
FAQ
What were AtriCure, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AtriCure, Inc. reported EPS of -$0.01, beating estimates by 91.46%, and revenue of $134.27M, 0.29% above expectations.
How did the market react to AtriCure, Inc.'s Q3 2025 earnings?
The stock price moved down -3.81%, changed from $35.44 before the earnings release to $34.09 the day after.
When is AtriCure, Inc. expected to report next?
The next earning report is scheduled for Feb 10, 2026.
What are the forecasts for AtriCure, Inc.'s next earnings report?
Based on 11
analysts, AtriCure, Inc. is expected to report EPS of -$0.09 and revenue of $142.05M for Q4 2025.